Patrick Walsh Email and Phone Number
Patrick Walsh work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Patrick Walsh personal email
Patrick Walsh phone numbers
My focus is on creating strong leadership teams, coupled with best in class commercialization strategies, to consistently drive growth in numerous pharmaceutical and specialty pharma sectors. My tenure as either CEO or Executive Chairman in multiple organizations has been marked by strategic initiatives that enhanced our market position, added shareholder value and solidified our reputation with customers.Brings proficiency in navigating the complexities of the FDA regulatory landscape, led multiple high-profile transformative deals, and a proven track record of expanding the company footprint in the pharmaceutical and contract service industry.
-
Operating PartnerAmpersand Capital Partners Mar 2018 - PresentWellesley, Ma, Us
-
Executive ChairmanMedpharm Ltd Feb 2024 - PresentGuildford, Surrey, Gb -
Chairman Of The BoardAlcami Corporation Mar 2021 - PresentWilmington, Nc, Us -
Chairman Of The Board Of DirectorsAni Pharmaceuticals, Inc. May 2018 - PresentPrinceton, New Jersey, UsIndependent Director and serves on the compensation committee. -
Founder & ChairmanDiligence Group Llc Aug 2014 - PresentProvides consulting, strategic advisory and due diligence review.
-
Member Board Of DirectorsIce Pharma Sep 2019 - Apr 2024Reggio Emilia, It -
Board MemberLandec Corporation Oct 2020 - Aug 2021Chairman of the Lifecore Innovation Committee
-
Member Board Of DirectorsAvid Bioservices Oct 2017 - Mar 2021Tustin, California, UsIndependent Director and serves as Chair of the Compensation committee and a member of the Nominating Committee. -
Chief Executive OfficerTripharm Services, Now Part Of Alcami May 2019 - Apr 2020TriPharm is a CDMO providing aseptic fill and finish drug manufacturing services for biologic or small volume parenteral projects in liquid, lyophilized, syringe and vial product offerings. Alcami acquired TrIPharm Services in 2020.
-
Chief Executive OfficerAvista Pharma Solutions - Now Part Of Cambrex Jun 2015 - Mar 2019East Rutherford, New Jersey, UsRecruited by private equity firm Ampersand Capital to lead Avista Pharma Solutions, which became a preferred CDMO to the pharmaceutical industry in less than 4 years and was acquired by Cambrex Corp in January 2019. -
Chief Executive OfficerAlcami (Aaipharma Services Corp./ Cambridge Major Laboratories Inc.) Aug 2010 - Apr 2014Wilmington, Nc, UsRecruited by private equity firm Water Street Healthcare Partners to lead the successful turn-around of AAIPharma Services Corp. In four years, AAI tripled its customer base, doubled its revenues and increased its profitability more than 10-fold culminating in an outstanding return on invested capital upon its acquisition in October 2013.The business combination had over 1,000 employees across 7 locations in the U.S. and Europe offering API, Formulation, Analytical/Method Development, Manufacturing and Packaging capabilities.Patrick was also named CEO of the combined business post-acquisition and led the business through the initial integration phase till his resignation in April 2014. -
Chief Executive OfficerKadmus Pharmaceuticals, Inc Feb 2003 - Dec 2008Chief Executive Officer of a privately-heId, venture capital backed company that was acquired by Organon Biosciences while still at an "A" round valuation. Lead a three-tranche financing round of over $25 million, completed several key licensing transactions and intellectual property enhancements, hired a strong leadership team, secured cost-effective laboratory facility for advancing company technology and implemented 2 phase II clinical studies.
-
President And Chief Operating OfficerGensia Sicor Jun 1994 - Jun 1999Led a senior team of executives involved in all aspects of a growing $400 million specialty pharmaceutical and contract service business. Explosive growth over a 4 year period resulted in the successful merger of Gensia and Sicor creating a profitable, vertically integrated global, specialty pharmaceutical company. Gensia Sicor business combination employed over 2,000 employees in the U.S., Mexico & Europe and created one of the first vertically-integrated specialty pharma companies. Directed business and commercial marketing initiatives with emphasis in oncology, CNS, anesthesia, cardiovascular and specialty drug delivery markets. Managed a significant contract development and manufacturing business serving pharmaceutical and biotechnology companies on a global scale, introduced and marketed a comprehensive line of differentiated generic drugs, and served as a board of director of the publicly-traded company that was eventually acquired by Teva Industries for $3.4 billion.
-
Corporate Vice President, DirectorFujisawa Usa Jan 1985 - Jun 1994Originally hired by Lyphomed, then asked to assume greater leadership roles following LyphoMed's acquisition by Fujisawa Pharmaceuticals. Promoted 7 times over a 9 year period rising from District Sales Manager to eventually serving as Corporate VP leading the U.S. and international business groups for Fujisawa, USA. Reported directly to CEO of corporation overseeing a $500 million dollar business with over 400 employees in the business group. Conducted business in over 60 countries around the globe in raw material, global generics, specialty pharmaceutical products, and specialty brand products.
Patrick Walsh Skills
Frequently Asked Questions about Patrick Walsh
What company does Patrick Walsh work for?
Patrick Walsh works for Ampersand Capital Partners
What is Patrick Walsh's role at the current company?
Patrick Walsh's current role is Operating Partner | Executive Chairman.
What is Patrick Walsh's email address?
Patrick Walsh's email address is pa****@****rma.com
What is Patrick Walsh's direct phone number?
Patrick Walsh's direct phone number is (919) 544*****
What are some of Patrick Walsh's interests?
Patrick Walsh has interest in Æè², Education.
What skills is Patrick Walsh known for?
Patrick Walsh has skills like Leadership, Entrepreneurship, Contract Manufacturing, Due Diligence, Pharmaceutical Industry, Fda, Gmp, Mergers And Acquisitions, Drug Development, Commercialization, Product Development, Clinical Trials.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial